Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.66 | 33.78 |
PEG Ratio (TTM) | 0.00 | 2.40 |
P/S Ratio (TTM) | 1.51 | 14.35 |
P/B Ratio (TTM) | 0.94 | 17.47 |
P/FCF Ratio (TTM) | -2.56 | 41.43 |
Price to 5YR AVG Earnings Ratio | N/A | 15.36 |
Price to 5YR AVG FCF Ratio | N/A | 57.41 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -105.16% | 12.83% |
ROE (TTM) | -154.36% | -4.27% |
Net Profit Margin (TTM) | -216.98% | 26.05% |
ROIC 5YR AVG | N/A | 5.46% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -87.50% | 10.77% | N/A |
Revenue | -13.97% | 95.38% | N/A |
Net Income | -106.92% | 8.58% | N/A |
Cash Flow | -1.04% | -87.63% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.58 | 1.38 |
Quick Ratio (TTM) | 1.58 | 1.36 |
D/E Ratio (TTM) | 0.04 | 1.12 |
Interest Coverage (TTM) | 0.00 | 39.34 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | N/A | 8.86 |
LTL to 5YR AVG FCF | N/A | 5.36 |
Shares Outstanding Growth 5YR AVG | N/A | 0.24% |